Activating Transcription Factor 4
Medicine & Life Sciences
100%
3-((1H-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
Medicine & Life Sciences
69%
Amino Acids
Medicine & Life Sciences
61%
SN-38
Chemical Compounds
52%
Colorectal Neoplasms
Medicine & Life Sciences
46%
TNF Receptor-Associated Factor 2
Medicine & Life Sciences
44%
Resistance
Chemical Compounds
44%
HCT116 Cells
Medicine & Life Sciences
44%
Takahashi, M. ,
Okamoto, Y. ,
Kato, Y. ,
Shirahama, H. ,
Tsukahara, S. ,
Sugimoto, Y. &
Tomida, A. ,
2023 4月 ,
In: Heliyon. 9 ,
4 , e14799.
研究成果: Article › 査読
Activating Transcription Factor 4
100%
Phosphatidylinositol 3-Kinases
64%
Cell Survival
49%
Amino Acids
45%
Mutation
36%
Takahashi, C. ,
Kondo, S. ,
Sadaoka, K. ,
Ishizuka, S. ,
Noguchi, K. ,
Kato, Y. &
Sugimoto, Y. ,
2020 9月 10 ,
In: Biochemical and Biophysical Research Communications. 530 ,
1 ,
p. 230-234 5 p. 研究成果: Article › 査読
TNF Receptor-Associated Factor 2
100%
HCT116 Cells
84%
Protein Kinases
60%
JQ1
54%
Cyclins
52%
Kato, Y. ,
Kunimasa, K. ,
Takahashi, M. ,
Harada, A. ,
Nagasawa, I. ,
Osawa, M. ,
Sugimoto, Y. &
Tomida, A. ,
2020 12月 ,
In: Molecular Pharmacology. 98 ,
6 ,
p. 669-676 8 p. 研究成果: Article › 査読
3-((1H-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
100%
Activating Transcription Factor 4
65%
Starvation
46%
Amino Acids
29%
Eukaryotic Initiation Factors
23%
Kato, Y. ,
Kondo, S. ,
Itakura, T. ,
Tokunaga, M. ,
Hatayama, S. ,
Katayama, K. &
Sugimoto, Y. ,
2020 1月 1 ,
In: Biochemical and Biophysical Research Communications. 521 ,
1 ,
p. 152-157 6 p. 研究成果: Article › 査読
SN-38
100%
Methotrexate
77%
Cisplatin
67%
Side-Population Cells
62%
Antineoplastic Agent
55%
Kondo, S. ,
Kato, Y. ,
Minagawa, S. &
Sugimoto, Y. ,
2020 3月 12 ,
In: Biochemical and Biophysical Research Communications. 523 ,
3 ,
p. 672-677 6 p. 研究成果: Article › 査読
Glutaminase
100%
Glutathione
62%
Clone Cells
55%
Pharmacological Metabolism
53%
Up-Regulation
49%